The effect of the possible influence of a new calcium antagonist, PY 108-068, on regional CBF was studied in patients suffering acute ischemic stroke. The dosage was 1.5 + 2.5 mg intravenously in six patients (series 1) and 2.5 + 5.0 mg intravenously in five other patients (series 2). CBF was measured before and after treatment by xenon-133 inhalation and single-photon emission computed tomography (Tomomatic 64). In the first series, no changes in hemispheric CBF, MABP, or
Over recent years, much effort has been placed in the investigation of the pathophysiological mech anisms that lead to irreversible cell damage fol lowing ischemia. Several studies now seem to indi cate that disturbances in calcium ion homeostasis may be responsible for the initiation of a series of events leading to irreversible cell damage. Fol lowing ischemia, a decline of high-energy phos phates is seen, with an accumulation of lactic acid and NADH (Siesjo, 1978) . If CBF decreases to levels between 16 and 20 mlllOO glmin, electrical activity will fail, leading to depolarization of the cell membrane (Branston et aI., 1974) with failure of the ionic pump at a somewhat lower flow level (Astrup et aI., 1977; Branston et ai., 1977) . At this point, calcium ions have been shown to enter the cells from the extracellular compartment, probably owing to an increased membrane permeability caused by depolarization or lowering of the cellular energy reserves (Harris et ai., 1981) . It has been suggested that this shift initiates a series of events that lead to intracellular accumulation of free fatty acids, in particular arachidonic acid (Wieloch and clinical symptoms were noted after treatment, but one patient showed an increase of CBF in part of the periin farct area. In the second series, slight increases in mean hemispheric flow values were seen, but in three of the five patients CBF decreased even further in the ischemic area. MABP decreased by 13%, and the clinical symptoms were unchanged. Key Words: Calcium antago nist-Cerebral blood flow-Ischemic stroke. Siesj6, 1982) . These substances have detrimental effects on the function of several cellular mecha nisms, causing an uncoupling of the oxidative phos phorylation, and may further change the perme ability of the cellular membranes [for review see Siesj6 (1981) ].
Based on these results, it could be expected that treatment with calcium antagonists in the early phase after cerebral ischemia might prevent the in tracellular calcium ion accumulation. These drugs might furthermore increase CBF by dilation of the vessels surrounding the ischemic area. However, conflicting results from experimental studies have been reported over the last years.
A new potent calcium antagonist of the dihydro peridine type that is chemically related to nifedi pine, PY lO8-068, has been developed (by Sandoz Ltd., Basel, Switzerland). In vitro studies have documented the calcium antagonistic properties of this drug as a selective inhibitor of the calcium-in duced contraction of the aorta (rabbit) and cerebral arteries (cat) (Hof et aI., 1982a,b) . Furthermore, experimental studies have shown a beneficial effect of PY lO8-068 in three different models of cerebral ischemia (Wiernsperger et aI., 1984) .
Consequently, we decided to study the effect of PY lO8-068 on the cerebral circulation in patients with acute stroke, measuring CBF by the atrau matic xenon-133 inhalation technique and single photon emission tomography.
MATERIALS AND METHODS
CBF was measured using xenon-133 inhalation and a r�pidly rotating detector system, the To momatic 64, pre vIOusly described in detail (Stokely et aI., 1980) . This technique permits the repetition of measurements using minimum intervals of 20 min. One study lasts 4.5 min, during which the patient inhales xenon-133 during the first 1.5 min from a closed system with a volume of 4.5 L and an initial xenon concentration of 20 mCi/L. The iso tope distribution during the xenon inhalation period and the three following I-min periods of xenon washout is re corded, yielding a sequence of four tomographic pictures. Three slices of brain tissue are studied simultaneously. These slices are 2 cm thick and have an inters lice dis tance of 2 cm. The resolution is 1.5 -I. 7 cm full width at half-maximum in the plane. The input function is taken from the lung curve profile obtained from a single nar rowly collimated crystal placed above the upper part of the lung. Calculation of CBF is then performed, applying the bolus distribution principle on the sum of the first two pictures. Scaling and linearization are performed as de scribed by Celsis et al. (1981) .
Although Compton-scattered radiation hinders the cal culation of true low flow values, the technique is well suited for the recognition of fo cal hypoperfused areas. Direct comparison of the tomographic flow pictures with the computed tomography (CT) scanning at the corre sponding level was performed. This allowed for the delin eation of low-flow areas corresponding to infarcted areas as well as low-flow areas where no hypodense lesions were present. Normally the levels are placed 5 and 9 cm above the orbitomeatal plane (OM), i.e., OM + 5 and O� + 9, respectively. By encircling the selected regions With a cursor, mean CBF values from these regions as well as the symmetrically placed region in the contrala teral hemisphere are obtained. Mean hemispheric CBF values were calculated in the same way for all pixels cor responding to brain tissue.
Statistics
To detect significant changes in a hypoperfused area, the variance in CBF in the low-flow region was calcu lated from 12 acute stroke cases (including the 5 stroke cases in the present series) studied twice within I h. The mean flow in the visually depicted focal low-flow area as well as the value in the symmetrically placed region in the contralateral (healthy) hemisphere were then calculated. Ta king the difference of these values as a percentage of the highest value yields the degree of side-to-side asym metry, D. Ta king the mean value of the variances ob tained from all 12 stroke patients (using the squared stan dard deviation of the two D values obtained fr om each individual patient), a significant (p < 0.05) change in D may be calculated by testing for the difference between two means (Zar, 1974) . Thus, when comparing the third measurement with two baseline studies, a change of >7 was shown to be required to reach significance, whereas in patients with only one baseline study, a change of >8 was required. In addition to this requirement, a positive effect of PY 108-068 was considered only if such signifi cant changes in the flow pattern occurred concomitantly with an increase of CBF in the low-flow area.
Patient material
Two subsequent series of patients with acute ischemic stroke were studied, excluding patients with previous ce rebrovascular disease. Patients with concomitant medical diseases, i.e., severe liver or renal insufficiency, severe hypertension, subclinical or evident cardiac insufficiency or heart blockade, as well as patients receiving treatment with other vasodilators or [3-blockers were excluded. Then, only patients showing a focal low-flow area (D > 10%) on the tomographic CBF measurement in conso nance with the clinical symptoms were further investi gated using PY 108-068. The patients were studied as soon as possible after admittance to the hospital, but no patient could be included later than day 10. Written and oral information concerning the type of study was given to the patient or a relative to obtain oral consent. The study was approved by the Ethical Committee in Copen hagen.
The first series comprised three men and three women (mean age 56 years, ranging from 20 to 81 years). These patients had suffered moderate to severe strokes, and all showed hypodense lesions on the CT scan in agreement with the clinical symptoms. The locations of the hypo perfused areas seen on the tomographic flow maps corre sponded to the CT lesions but were more extensive and thus present in periinfarct regions as well. Angiography was performed in four cases: One patient had a severe thread-like stenosis of the internal carotid artery, one showed an occlusion of the middle cerebral artery, whereas the remaining two showed no occlusions of the cerebral or precerebral arteries. CBF was measured from 1 to 9 days after onset of the stroke (average 5 days). A resting CBF measurement was performed and was re peated 50 min after doses of 1.5 and 2.5 mg, respectively. The drug was given by intravenous infusion at a rate of I mg PY 108-068 over 10 min.
In the second series, three men and two women (mean age of 56 years, ranging from 43 to 71 years) were studied. The clinical symptoms and the findings on the CT scan and by angiography are presented in Ta ble 1. CBF was measured from 2 to 7 days after onset (average 4 days). In these patients, two baseline studies were per formed with a minimum time interval of 20 min. Then continuous intravenous infusion of PY 108-068 was given at a rate of 1 mgllO min. CBF was measured when total doses of 2.5 and 7.5 mg had been reached.
In both series, the electrocardiogram was monitored continuously, and arterial blood pressure was recorded �y auscultation every 15 min. End-expiratory CO2 fr ac tIOn (Feco2) was measured by an infrared capnograph during and at the end of each CBF measurement. Neuro logical scoring was done before administration of PY 108-068 and repeated after the last CBF measurement.
RESULTS
In the first six cases, only one patient showed a significant change in the flow pattern. This patient showed an increase of CBF from 29 to 35 mi/lOO g/min in part of the periinfarct area, improving the side-to-side asymmetry from 31 to 20%. In the re maining, no significant changes in either mean CBF or flow distribution were seen. Mean hemispheric flow values for the nonaffected and affected sides were 52 ± 15 and 46 mlll00 g/min ± 13 (I SD), respectively, for the first CBF measurement. In the low-flow (infarcted) area, the value was consider ably lower, the lowest being 27 mlilOO g/min. The subsequent measurements during PY 108-068 treat ment both yielded mean values of 52 and 47 mlilOO g/min for the nonaffected and affected hemi spheres, respectively. The standard deviation of change from the baseline study reached values of 8 and 6 mlll00 g/min for either hemisphere. FeC02 values were unchanged. MABP just after the CBF measurement was 102, 100, and 102 mm Hg, and the heart rate was stable at � 100 beats/min. In the second series where the higher doses of PY 108-068 were used, slight increases in mean hemispheric CBF of 5 and 3% in the nonaffected and affected sides, respectively, were seen during treatment. However, significant changes in flow distribution were induced in three patients, who showed an even further decrease in CBF in the ischemic region with clear-cut aggravation of the side-to-side asymmetry (Figs. 1 and 2) . CBF was reduced in both the infarcted tissue and the periin farct regions (Table 2) . FeC02 values were un changed, showing values of 4.5 ± 0.4 , 4.5 ± 0.6, and 4.3 ± 0.6% (1 SD). MABP measured just after the first CBF measurements was 109 ± 12 mm Hg, and decreased to 95 ± 11 and 98 ± 15 mm Hg (1 SD) during infusion. The corresponding heart rates were 76, 84, and 82 beats/min. 
DISCUSSION

Methodological considerations
The tomographic approach for measurement of CBF using xenon-I33 inhalation permits identifica tion of focal low-flow areas in superficial as well as deeper brain structures, although these regions are recognized only when having a certain size and de gree of ischemia. These limits are set by the resolu tion of the equipment, as regions smaller than the resolution element (measured as full width at half maximum) may be overlooked owing to effects of partial volume and Compton scatter. However, ear lier studies have demonstrated that the technique is well suited for studies in patients with cerebrovas cular disease, as focal low-flow areas or focal hy peremias could be identified in the majority of pa tients with suspected lesions in the cerebral hemi spheres.
As the arterial input curve is estimated from the lung curve profile, truly quantitative CBF data are not obtained, but the flow distribution, i.e., the rel ative interpixel values within a flow picture, is cor rect. Consequently, in the evaluation of the results in the present series, major emphasis was placed on the calculations of the degree of side-to-side asym metry (D) for any region of interest. As these values refer only to changes occurring within the flow picture, direct comparison of D values can be performed between measurements where changes in mean CBF may have occurred. How- The values given in percentages indicate the degree of side-to-side asymmetry. whereas the values in parentheses show CBF values in mIll 00 g/min in the same periinfarct regions. a Significant (p < 0.05) change in side-to-side asymmetry as compared with the baseline value. ever, when studying the effect of drugs that aim at increasing the cerebral circulation in low-flow areas in particular, absolute flow values have also to be considered. The reproducibility of CBF measure ments in patients and normal volunteers has been presented in detail elsewhere (Shirahata et aI., 1985) . Relevant for the present study was the finding of the variance for D in low-flow areas in acute stroke, which showed that a change of >8% in the degree of side-to-side asymmetry was re quired to be significant (p < 0.05).
Pathophysiological changes in ischemia
Measurements of CBF in various models of cere bral ischemia have shown large variations in the lo cation and degree of ischemia. These changes have been noted within the same series of animals de spite standardization of the procedures (Blair and Waltz, 1970; Hossmann and Kleihues, 1973; Ta mura et aI., 1980; Kagstr�m et aI., 1983a) . Under such experimental conditions, the variations in the resulting acute flow patterns may best be explained by anatomic differences, i.e., the ability of the cere bral circulation to compensate by flow through col lateral channels. In some of the studies, the in crease in perfusion pressure after termination of the ischemic period causes very high focal increases in CBF, but in most studies this was invariably fol lowed by a state of delayed hypoperfusion, indi cating permanent cellular injury (Kagstr�m et aI., 1983a,b; Steen et aI., 1983) . The phenomenon of no-reflow has been reported to occur following alle viation of both incomplete and complete ischemia (Hossmann and Kleihues, 1973; Kagstr�m et aI., 1983b) . It was suggested that no-reflow following incomplete ischemia was due to the aggregation of blood elements during reduced flow levels, whereas when present following complete ischemia, the opening pressure of the collapsed vessels was too high to allow recirculation. Even after initial no-re-flow, however, delayed hypoperfusion was seen after some hours.
Direct visualization of the cerebral arteries has been performed in experimental cerebral ischemia. In the studies of Te asdale et al. (1981) , arteriolar vasoconstriction was shown to occur distal to an occlusion of a major intracerebral vessel, whereas Blair and Waltz (1970) observed both dilatation and constriction of the vessels in the squirrel monkey after occlusion of the middle cerebral artery. It must be assumed that if perfusion pressure drops to near zero values distal to an occlusion, then the smaller vessels collapse. In the situation with higher perfusion pressure, the vessel wall may re main distended, and metabolic factors as changes in pH due to ischemic lactacidosis may add further to the vasodilation-which, on the other hand, might be counterbalanced by a vasoconstrictor ef fect due to intracellular accumulation of calcium. Furthermore, the rheology of the circulating blood and the extravascular tissue pressure may become important in these low-flow areas.
In the clinical setting, the pathogenetic events leading to symptoms of cerebral ischemia differ considerably. Acute symptoms of cerebral ischemia may be the result of distal embolism from the large neck vessels or from the heart, which occludes an intracerebral artery. In other cases, an occlusion of the internal carotid artery is shown to be the cause of the symptoms. In still other cases, a lacunar in farct, i.e., a small strategic lesion probably due to thrombosis of a striate artery, is demonstrated as the pathophysiological mechanism. Consequently, uniform CBF patterns and changes in the vascula ture cannot be expected to occur in the patient pop ulation.
Measurement of CBF in stroke patients has shown that focal low-flow areas are often seen in the acute phase (Paulson, 1971; U emura et al., 1978; Skyh�j Olsen et aI., 1981) . Concomitant mea- computed tomography scan showed no lesions, but the repeated scan 2 months later showed an infarct in the left parietal lobe. Carotid angiography showed a "thread-like" internal carotid artery. The CBF measurements performed 4 days after onset showed a large low-flow area affecting most of the left hemisphere. After treatment with PY 108-068 (regimen of series 2 using the higher doses), CBF increased in the healthy hemisphere, but a decrease was seen in the infarct and periinfarct regions.
Corresponding levels of the CT scan and the CBF tomograms are shown, placed 5 and 9 cm above the orbitomeatal plane.
surements of CMR02 using positron emission to mography have indicated (Wise et al., 1983 ) that potentially viable brain tissue may be present for some days after onset of an acute stroke. This was J Cereb Blood Flow Metab, Vol. 6, No, 2, 1986 suggested by the finding of hypoperfused areas having an increased oxygen extraction ratio with preserved CMR02, which was observed in one third of the patients studied within day 3. In such in the acute and chronic phase showed an infarct in the right occipital lobe. Angiography showed that the right internal carotid artery was occluded. CBF studies were performed 5 days after onset. Before treatment, a reduced flow was seen in the infarct and periinfarct regions. After PY 108-068 administration (regimen of series 2 using the higher doses), a slight CBF increase was seen in the left hemisphere, but CBF decreased in the right occipital area. Corresponding levels of the CT scan and the CBF tomograms are shown, placed 5 and 9 cm above the orbitomeatal plane.
patients, improvement of the clinical outcome by early treatment with a calcium antagonist could be expected on theoretical grounds. However, in sev eral patients, very early transition of the hypoper-fused area to hyperemia is seen (Skyh�j Olsen et aI., 1981) , probably owing to dissolution or distal migration of embolic material. In these patients, as well as in patients having lacunar infarcts in the white matter that cause only remote reductions in CBF probably due to diaschisis or undercutting of neuronal fibers (Takano et aI., 1985; S. Vorstrup et aI., unpublished observation) , treatment with cal cium antagonists is less likely to have an effect. In the present series, only patients with focal low-flow areas were studied.
Calcium antagonists in cerebral ischemia
The vasodilating properties of calcium antago nists in nonischemic animal models have been dem onstrated in several studies: by direct measure ments of the vessel diameter (Auer, 198 I) or by measurement of the resultant flow (Harper et aI., 1981; Brandt et aI., 1983; Haws et aI., 1983) . How ever, Harris et al. (1982) found only an insignificant increase of the basal blood flow level following ni modi pine treatment in a closed-skull primate model. These results correspond to our findings, where only a slight increase of CBF was noted in the nonaffected hemisphere. Their study also dem onstrated that responses to arterial Pco2 changes and autoregulation to reduced blood pressure were severely impaired during treatment.
In experimental cerebral ischemia, the effects of treatment given before and after the insult have been studied. Steen et al. (1983) In the present study, treatment with a calcium antagonist did not improve CBF in the ischemic area or its surroundings, not even in the case studied 1 day after onset of clinical symptoms. But an even further CBF decrease was observed in some of the patients from the group given the higher doses of calcium antagonist. On the pre sumption that the vessels in the ischemic areas are vasoparalytic, this could be explained by a "steal effect." Thus, the decrease in perfusion pressure caused by cerebral vasodilation elsewhere and the reduction in systemic blood pressure noted in these patients could decrease CBF in the ischemic area and its surroundings. In an experimental study using nimodipine, Mohamed et al. (1984) also showed that increasing doses of a calcium antago nist may lead to a decrease of the MABP. The de crease in MABP counteracts the effect of the cere brovascular relaxation, which is of particular im portance in cerebral ischemia where regi�n�1 perfusion pressure is reduced below the lower hmlt of CBF autoregulation.
The present study did not show any beneficial hemodynamic effect of treatment with a calcium antagonist (PY 108-068) in the early phase after an acute stroke. It could be expected, however, that under different pathophysiological conditions, where cerebral ischemia occurs owing to severe va soconstriction of the cerebral vessels as seen after a subarachnoid hemorrhage, treatment with a cal cium antagonist might prove useful (Allen et aI., 1983) . Still, it can not be excluded that patients with acute stroke might benefit by treatment with a calcium antagonist owing to a protective effect at the cellular level, in particular if treatment could be given before onset of the symptoms. Such docu mentation would need more extensive experimental studies in various stroke models and clinical docu mentation in large-scale double-blind studies.
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